Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Authors
Keywords
-
Journal
SCIENCE
Volume -, Issue -, Pages eabb5920
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-12-11
DOI
10.1126/science.abb5920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade
- (2020) Allison Betof Warner et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel patterns of response under immunotherapy
- (2019) E Borcoman et al. ANNALS OF ONCOLOGY
- Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis
- (2019) Samuel P. Costello et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
- (2019) Takeshi Tanoue et al. NATURE
- Modulating the microbiome to improve therapeutic response in cancer
- (2019) Jennifer L McQuade et al. LANCET ONCOLOGY
- Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
- (2019) Evan Bolyen et al. NATURE BIOTECHNOLOGY
- Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond
- (2018) Jeffrey E. Gershenwald et al. ANNALS OF SURGICAL ONCOLOGY
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation
- (2018) Christopher S. Smillie et al. Cell Host & Microbe
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection
- (2018) Umair Iqbal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Anti-PD-1 antibody treatment for melanoma
- (2018) Antoni Ribas et al. LANCET ONCOLOGY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature
- (2018) Steven C Lin et al. Transplant Infectious Disease
- The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
- (2018) David A. Schaer et al. Cell Reports
- Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
- (2018) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features
- (2018) Niv Zmora et al. CELL
- T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
- (2018) Jonathan A. Trujillo et al. Cancer Immunology Research
- Specific Bacteria and Metabolites Associated with Response to Fecal Microbiota Transplantation in Patients with Ulcerative Colitis
- (2018) Sudarshan Paramsothy et al. GASTROENTEROLOGY
- Species-level functional profiling of metagenomes and metatranscriptomes
- (2018) Eric A. Franzosa et al. NATURE METHODS
- Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
- (2018) Paolo A. Ascierto et al. JAMA Oncology
- European consensus conference on faecal microbiota transplantation in clinical practice
- (2017) Giovanni Cammarota et al. GUT
- Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer
- (2017) Reinhard Büttner et al. JOURNAL OF CLINICAL ONCOLOGY
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- Exhaustion-associated regulatory regions in CD8+tumor-infiltrating T cells
- (2017) Giuliana P. Mognol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- A role for bacterial urease in gut dysbiosis and Crohn’s disease
- (2017) Josephine Ni et al. Science Translational Medicine
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Preparing the Gut with Antibiotics Enhances Gut Microbiota Reprogramming Efficiency by Promoting Xenomicrobiota Colonization
- (2017) Shou K. Ji et al. Frontiers in Microbiology
- Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
- (2016) Ilan Youngster et al. BMC Medicine
- Enrichment dynamics of Listeria monocytogenes and the associated microbiome from naturally contaminated ice cream linked to a listeriosis outbreak
- (2016) Andrea Ottesen et al. BMC MICROBIOLOGY
- Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
- (2016) E. R. Parra et al. CLINICAL CANCER RESEARCH
- Peripheral Lymphoid Volume Expansion and Maintenance Are Controlled by Gut Microbiota via RALDH+ Dendritic Cells
- (2016) Zongde Zhang et al. IMMUNITY
- A Harmonization Study for the Use of 22C3 PD-L1 Immunohistochemical Staining on Ventana’s Platform
- (2016) Tzahi Neuman et al. Journal of Thoracic Oncology
- Cross-talk among flesh-eatingAeromonas hydrophilastrains in mixed infection leading to necrotizing fasciitis
- (2016) Duraisamy Ponnusamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- An Integrative View of Microbiome-Host Interactions in Inflammatory Bowel Diseases
- (2015) Marta Wlodarska et al. Cell Host & Microbe
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Tumor-intrinsic oncogene pathways mediating immune avoidance
- (2015) Stefani Spranger et al. OncoImmunology
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- Microbial Community Profiling of Human Saliva Using Shotgun Metagenomic Sequencing
- (2014) Nur A. Hasan et al. PLoS One
- Visual account of protein investment in cellular functions
- (2014) W. Liebermeister et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ANOVA-Like Differential Expression (ALDEx) Analysis for Mixed Population RNA-Seq
- (2013) Andrew D. Fernandes et al. PLoS One
- Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy
- (2012) Apar Pataer et al. Journal of Thoracic Oncology
- Metagenomic microbial community profiling using unique clade-specific marker genes
- (2012) Nicola Segata et al. NATURE METHODS
- Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
- (2011) Johan S. Bakken et al. Clinical Gastroenterology and Hepatology
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now